Impact of Optimal Medical Therapy and Revascularization on Outcome of Patients With Chronic Kidney Disease and on Dialysis Who Presented With Acute Coronary Syndrome

American Journal of Cardiology

Volumn 102, Issue 5, 2008, Pages 535-540

  Bonello, Laurent ^a   De Labriolle, Axel ^a   Roy, Probal ^a   Steinberg, Daniel H ^a   Okabe, Teruo ^a   Slottow, Tina L Pinto ^a   Xue, Zhenyi ^a   Torguson, Rebecca ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; AGED; ANAMNESIS; ARTICLE; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CREATININE CLEARANCE; DIALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION;

ACUTE DISEASE; AGED; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 51749107735     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.040     Document Type: Article

References (29)

1. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
2. McCullough P.A. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 41 (2003) 725-728
3. Winkelmayer W.C., Charytan D.M., Brookhart M.A., Levin R., Solomon D.H., and Avorn J. Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol 1 (2006) 796-801
4. Charytan D., Mauri L., Agarwal A., Servoss S., Scirica B., and Kuntz R.E. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J 152 (2006) 558-564
5. Berger A.K., Duval S., and Krumholz H.M. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 42 (2003) 201-208
6. Schiele F., Legalery P., Didier K., Meneveau N., Seronde M.F., Caulfield F., Ducloux D., Bechetoille P., Magnin D., Faivre R., and Bassand J.P. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am Heart J 151 (2006) 661-667
7. Keeley E.C., Kadakia R., Soman S., Borzak S., and McCullough P.A. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 92 (2003) 509-514
8. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
9. Herzog C.A., Littrell K., Arko C., Frederick P.D., and Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116 (2007) 1465-1472
10. Johnston N., Jernberg T., Lagerqvist B., and Wallentin L. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. Am Heart J 152 (2006) 1052-1058
11. Yasuda K., Kasuga H., Aoyama T., Takahashi H., Toriyama T., Kawade Y., Iwashima S., Yamada S., Kawahara H., Maruyama S., et al. Comparison of percutaneous coronary intervention with medication in the treatment of coronary artery disease in hemodialysis patients. J Am Soc Nephrol 17 (2006) 2322-2332
12. Tricoci P., Lokhnygina Y., Berdan L.G., Steinhubl S.R., Gulba D.C., White H.D., Kleiman N.S., Aylward P.E., Langer A., Califf R.M., et al. Time to coronary angiography and outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Circulation 116 (2007) 2669-2677
13. Herzog C.A., Ma Stigant C., Izadnegahdar M., Levin A., Buller C.E., and Humphries K.H. Outcomes after percutaneous coronary interventions in patients with CKD: improved outcome in the stenting era. Am J Kidney Dis 45 (2005) 1002-1009
14. Hassani S.E., Chu W.W., Wolfram R.M., Kuchulakanti P.K., Xue Z., Gevorkian N., Suddath W.O., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., and Waksman R. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 18 (2006) 273-277
15. Halkin A., Selzer F., Marroquin O., Laskey W., Detre K., and Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Invasive Cardiol 18 (2006) 577-583
16. Shlipak M.G., Fried L.F., Crump C., Bleyer A.J., Manolio T.A., Tracy R.P., Furberg C.D., and Psaty B.M. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107 (2003) 87-92
17. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607-617
18. Robinson K., Gupta A., Dennis V., Arheart K., Chaudhary D., Green R., Vigo P., Mayer E.L., Selhub J., Kutner M., and Jacobsen D.W. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94 (1996) 2743-2748
19. Moustapha A., Naso A., Nahlawi M., Gupta A., Arheart K.L., Jacobsen D.W., Robinson K., and Dennis V.W. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97 (1998) 138-141
20. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., and Barre P.E. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28 (1996) 53-61
21. Choi J.H., Kim K.L., Huh W., Kim B., Byun J., Suh W., Sung J., Jeon E.S., Oh H.Y., and Kim D.K. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24 (2004) 1246-1252
22. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M., and Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
23. Bonello L., Basire A., Sabatier F., Paganelli F., and Dignat-George F. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. Thromb Haemost 4 (2006) 979-981
24. Ganesh S.K., Hulbert-Shearon T., Port F.K., Eagle K., and Stack A.G. Mortality differences by dialysis modality in incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 14 (2003) 415-424
25. Walsh M., Culleton B., Tonelli M., and Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 (2005) 1500-1508
26. Culleton B.F., Walsh M., Klarenbach S.W., Mortis G., Scott-Douglas N., Quinn R.R., Tonelli M., Donnelly S., Friedrich M.G., Kumar A., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 19 (2007) 1291-1299
27. Dimeny E.M. Cardiovascular disease after renal transplantation. Kidney Int 61 (2002) s78-s84
28. Lahoz C., Mostaza J.M., Mantilla M.T., Taboada M., Tranche S., López-Rodriguez I., Monteiro B., Soler B., Sanchez-Zamorano M.A., and Martin-Jadraque R. Achievement of therapeutic goals and utilization of evidence-based cardiovascular therapies in coronary heart disease patients with chronic kidney disease. Am J Cardiol 101 (2008) 1098-1102
29. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., Van Lente F., and Levey A.S. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047